Imprint Wealth LLC bought a new stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 131,737 shares of the medical research company’s stock, valued at approximately $13,174,000. Imprint Wealth LLC owned approximately 0.07% of IQVIA at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of IQV. Mutual Advisors LLC increased its holdings in shares of IQVIA by 3.1% during the second quarter. Mutual Advisors LLC now owns 1,602 shares of the medical research company’s stock worth $360,000 after purchasing an additional 48 shares during the period. Parkside Financial Bank & Trust lifted its stake in shares of IQVIA by 19.6% in the second quarter. Parkside Financial Bank & Trust now owns 293 shares of the medical research company’s stock worth $66,000 after acquiring an additional 48 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd boosted its stake in shares of IQVIA by 1.1% in the 2nd quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 5,034 shares of the medical research company’s stock valued at $1,131,000 after purchasing an additional 55 shares during the last quarter. Byrne Asset Management LLC grew its holdings in IQVIA by 0.8% during the 2nd quarter. Byrne Asset Management LLC now owns 6,709 shares of the medical research company’s stock worth $1,508,000 after acquiring an additional 56 shares during the period. Finally, Penserra Capital Management LLC lifted its stake in IQVIA by 6.1% in the fourth quarter. Penserra Capital Management LLC now owns 971 shares of the medical research company’s stock valued at $198,000 after buying an additional 56 shares during the period. 86.82% of the stock is owned by institutional investors.
IQVIA Price Performance
Shares of IQVIA stock traded up $1.36 during trading hours on Monday, reaching $206.15. 850,109 shares of the company’s stock were exchanged, compared to its average volume of 1,096,962. The company has a market capitalization of $37.62 billion, a P/E ratio of 34.42, a price-to-earnings-growth ratio of 2.64 and a beta of 1.42. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 2.12. IQVIA Holdings Inc. has a 1 year low of $167.42 and a 1 year high of $241.86. The business has a fifty day moving average of $197.42 and a two-hundred day moving average of $207.40.
Wall Street Analysts Forecast Growth
IQV has been the subject of a number of analyst reports. Stifel Nicolaus lifted their price target on IQVIA from $255.00 to $281.00 and gave the company a “buy” rating in a research note on Wednesday, August 2nd. Mizuho lowered their target price on shares of IQVIA from $250.00 to $229.00 and set a “buy” rating on the stock in a report on Tuesday, October 10th. HSBC initiated coverage on shares of IQVIA in a research note on Wednesday, September 6th. They set a “buy” rating and a $260.00 price objective for the company. Citigroup lifted their price target on IQVIA from $200.00 to $225.00 and gave the company a “neutral” rating in a research report on Wednesday, August 2nd. Finally, Truist Financial cut their target price on shares of IQVIA from $260.00 to $240.00 and set a “buy” rating for the company in a research report on Friday, November 3rd. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $236.57.
IQVIA Company Profile
IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
- Five stocks we like better than IQVIA
- Learn Technical Analysis Skills to Master the Stock Market
- The most upgraded stocks in November have two things in common
- How to Invest in Blockchain Stocks Step by Step
- Monday.com rocked earnings like it’s the weekend
- Following Congress Stock Trades
- Plan to own one retailer? Make it this one
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.